PT1112067E - Utilizacao de inibidores de acetilcolinesterase para a preparacao de composicoes farmaceuticas para o tratamento de sindromas de dor funcional e/ou organica - Google Patents

Utilizacao de inibidores de acetilcolinesterase para a preparacao de composicoes farmaceuticas para o tratamento de sindromas de dor funcional e/ou organica

Info

Publication number
PT1112067E
PT1112067E PT99946150T PT99946150T PT1112067E PT 1112067 E PT1112067 E PT 1112067E PT 99946150 T PT99946150 T PT 99946150T PT 99946150 T PT99946150 T PT 99946150T PT 1112067 E PT1112067 E PT 1112067E
Authority
PT
Portugal
Prior art keywords
treatment
acetilcolinesterase
usefulness
inhibitors
functional
Prior art date
Application number
PT99946150T
Other languages
English (en)
Inventor
Nicolodi Maria
Sicuteri Federigo
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PT1112067E publication Critical patent/PT1112067E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
PT99946150T 1998-09-11 1999-09-09 Utilizacao de inibidores de acetilcolinesterase para a preparacao de composicoes farmaceuticas para o tratamento de sindromas de dor funcional e/ou organica PT1112067E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998FI000208A IT1304904B1 (it) 1998-09-11 1998-09-11 Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche

Publications (1)

Publication Number Publication Date
PT1112067E true PT1112067E (pt) 2006-09-29

Family

ID=11352669

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99946150T PT1112067E (pt) 1998-09-11 1999-09-09 Utilizacao de inibidores de acetilcolinesterase para a preparacao de composicoes farmaceuticas para o tratamento de sindromas de dor funcional e/ou organica

Country Status (12)

Country Link
US (1) US6608088B1 (pt)
EP (1) EP1112067B1 (pt)
JP (1) JP3984787B2 (pt)
AT (1) ATE327740T1 (pt)
AU (1) AU5861799A (pt)
CY (1) CY1105125T1 (pt)
DE (1) DE69931640T2 (pt)
DK (1) DK1112067T3 (pt)
ES (1) ES2265691T3 (pt)
IT (1) IT1304904B1 (pt)
PT (1) PT1112067E (pt)
WO (1) WO2000015205A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
PT1311272E (pt) 2000-03-03 2007-02-28 Eisai R&D Man Co Ltd Novos métodos utilizando inibidores de colinesterase
AU5522301A (en) * 2000-04-21 2001-11-26 Upjohn Co Treatment of fibromyalgia and chronic fatigue syndrome
WO2002083141A1 (en) * 2001-04-17 2002-10-24 Pharmacia & Upjohn Company Treatment of fibromyalgia and chronic fatigue syndrome
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung
KR20070097590A (ko) 2005-01-25 2007-10-04 에픽스 델라웨어, 인코포레이티드 치환된 아릴아민 화합물 및 5―ht6 조절제로서의 이의용도
JP5731094B2 (ja) * 2005-02-11 2015-06-10 スティーブン・ウィルスStephen WILLS アセチルコリンエステラーゼ阻害剤による微小血管系疾患の治療
RS51822B (en) * 2005-04-04 2012-02-29 Eisai R. &D. Management Co. Ltd. DIHYDROPYRIDINE COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND Dementia
CN101100455B (zh) 2006-07-05 2015-08-05 天津合美医药科技有限公司 具有镇痛作用的5,9-甲撑环辛并(b)吡啶-2(1H)酮衍生物及其制备和应用
US8012994B1 (en) 2006-09-22 2011-09-06 Sevastyanov Victor V Method for the treatment of sensorineural hearing loss with donepezil hydrochloride (ARICEPT®)
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
ZA200905537B (en) 2007-03-01 2010-10-27 Probiodrug Ag New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
US8138169B2 (en) 2008-04-11 2012-03-20 Comgenrx, Inc. Combination therapy for bipolar disorder
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
CA2789014C (en) 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
JP2015078129A (ja) * 2012-02-01 2015-04-23 株式会社新日本科学 ドネペジルを含む線維筋痛症の治療剤
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010083A (en) * 1988-03-28 1991-04-23 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-methano-1,3-benzodiazocine compounds which have useful pharmaceutical utility
DE3927049A1 (de) * 1989-08-16 1991-02-21 Sandoz Ag Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung
US5336675A (en) 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
GB9606736D0 (en) 1996-02-19 1996-06-05 Shire International Licensing Therapeutic method
WO1999008672A1 (en) * 1997-08-15 1999-02-25 Shire International Licensing Bv Use of cholinesterase inhibitor for treating diseases associated with proteolytic enzyme activity

Also Published As

Publication number Publication date
WO2000015205A2 (en) 2000-03-23
IT1304904B1 (it) 2001-04-05
US6608088B1 (en) 2003-08-19
DE69931640D1 (de) 2006-07-06
EP1112067B1 (en) 2006-05-31
ATE327740T1 (de) 2006-06-15
DE69931640T2 (de) 2007-03-08
ITFI980208A0 (it) 1998-09-11
EP1112067A2 (en) 2001-07-04
JP3984787B2 (ja) 2007-10-03
AU5861799A (en) 2000-04-03
WO2000015205A3 (en) 2000-08-24
ES2265691T3 (es) 2007-02-16
JP2002524498A (ja) 2002-08-06
CY1105125T1 (el) 2009-11-04
DK1112067T3 (da) 2006-09-04
ITFI980208A1 (it) 2000-03-11

Similar Documents

Publication Publication Date Title
PT1112067E (pt) Utilizacao de inibidores de acetilcolinesterase para a preparacao de composicoes farmaceuticas para o tratamento de sindromas de dor funcional e/ou organica
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
DK0751789T3 (da) Gel til behandling af hudsygdomme og til desinfektion af huden
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
SE9603669D0 (sv) New combination
BR9508373A (pt) Preparação farmacêutica uso da preparação farmacêutica e processos para preparar a preparação farmacêutica e para aliviar dor
YU7797A (sh) Kombinovana terapija za osteoporozu
ATE231872T1 (de) Thiazolopyrimidinderivate
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
NO20004419D0 (no) Ny anvendelse
HUP9901288A2 (hu) LHRH-analógokat és antiösztrogéneket tartalmazó kombinációs gyógyszerkészítmények nőgyógyászati zavarok kezelésére
PT1109814E (pt) 5-heterociclil pirazol¬4,3-d|pirimidina-7-onas para o tratamento da disfuncao erectil masculina
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ATE255094T1 (de) Piperazinderivate zur behandlung der niedrigen harnwege
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
BR0010560A (pt) 3-piridil-4-arilpirrois substituìdos e métodos terapêuticos e profiláticos relacionados
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
NO20005548D0 (no) Mykobakterieinhibitorer
ES2171080T3 (es) Composicion para la mejora de la fertilidad y su aplicacion.
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
ATE74505T1 (de) Schmerzpraeparat.